Autobio Diagnostics Co Ltd (603658) — Working Capital to Net Assets Ratio
Autobio Diagnostics Co Ltd (603658) has a Working Capital to Net Assets ratio of 40.7% as of September 2025. Working capital of CN¥3.60 Billion (current assets of CN¥5.88 Billion minus current liabilities of CN¥2.28 Billion) is measured against net assets of CN¥8.85 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Autobio Diagnostics Co Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Autobio Diagnostics Co Ltd Working Capital to Net Assets (2011–2024)
This chart shows how Autobio Diagnostics Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 40.7%, reflecting working capital of CN¥3.60 Billion against net assets of CN¥8.85 Billion CNY. Check how tangible is Autobio Diagnostics Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Autobio Diagnostics Co Ltd (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Autobio Diagnostics Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 603658 market cap overview.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 44.7% | CN¥3.88 Billion | CN¥8.69 Billion | CN¥6.54 Billion | CN¥2.66 Billion | ▼ -3.0 pp |
| 2023 | 47.7% | CN¥4.13 Billion | CN¥8.67 Billion | CN¥6.61 Billion | CN¥2.48 Billion | ▼ -4.0 pp |
| 2022 | 51.7% | CN¥4.09 Billion | CN¥7.91 Billion | CN¥6.25 Billion | CN¥2.17 Billion | ▼ -3.7 pp |
| 2021 | 55.4% | CN¥4.10 Billion | CN¥7.40 Billion | CN¥5.56 Billion | CN¥1.46 Billion | ▼ -2.9 pp |
| 2020 | 58.3% | CN¥3.84 Billion | CN¥6.59 Billion | CN¥5.09 Billion | CN¥1.26 Billion | ▲ +19.2 pp |
| 2019 | 39.1% | CN¥1.03 Billion | CN¥2.63 Billion | CN¥2.02 Billion | CN¥987.04 Million | ▲ +13.8 pp |
| 2018 | 25.3% | CN¥496.63 Million | CN¥1.97 Billion | CN¥1.11 Billion | CN¥610.79 Million | ▼ -3.5 pp |
| 2017 | 28.8% | CN¥486.01 Million | CN¥1.69 Billion | CN¥913.69 Million | CN¥427.69 Million | ▼ -33.7 pp |
| 2016 | 62.4% | CN¥1.03 Billion | CN¥1.64 Billion | CN¥1.18 Billion | CN¥148.34 Million | ▲ +22.9 pp |
| 2015 | 39.5% | CN¥284.00 Million | CN¥718.55 Million | CN¥414.64 Million | CN¥130.64 Million | ▲ +0.3 pp |
| 2014 | 39.3% | CN¥196.68 Million | CN¥500.94 Million | CN¥290.76 Million | CN¥94.08 Million | ▼ -6.6 pp |
| 2013 | 45.9% | CN¥156.27 Million | CN¥340.42 Million | CN¥215.32 Million | CN¥59.05 Million | ▼ -12.0 pp |
| 2012 | 57.9% | CN¥135.47 Million | CN¥233.84 Million | CN¥170.08 Million | CN¥34.61 Million | ▼ -6.5 pp |
| 2011 | 64.4% | CN¥101.15 Million | CN¥156.96 Million | CN¥126.50 Million | CN¥25.34 Million | — |